ATAI Life Sciences NV
(NAS:ATAI)
$
1.64
0.03 (1.86%)
Market Cap: 274.55 Mil
Enterprise Value: 184.09 Mil
PE Ratio: 0
PB Ratio: 1.22
GF Score: 32/100 - ATAI Life Sciences NV Announces Strategic Investment in Beckley Psytech Ltd Call TranscriptJan 04, 2024
- Q3 2022 ATAI Life Sciences NV Earnings Presentation TranscriptNov 10, 2022
- ATAI Life Sciences NV R&D Investor Day TranscriptOct 25, 2022
- ATAI Life Sciences NV at Citi BioPharma Conference TranscriptSep 07, 2022
- Q2 2022 ATAI Life Sciences NV Earnings Presentation TranscriptAug 15, 2022
- ATAI Life Sciences NV at Citi Biopharma Co-Panel Day (Virtual) TranscriptMay 18, 2022
- Q1 2022 ATAI Life Sciences NV Earnings Call TranscriptMay 16, 2022$4.04 (+10.99%)Earnings
- Q4 2021 ATAI Life Sciences NV Earnings Call TranscriptMar 30, 2022$5.34 (-1.48%)Earnings
- ATAI Life Sciences NV at Citi Winter Biotech Virtual Bus Tour TranscriptMar 22, 2022
- Atai Life Sciences N.V. - Special Call TranscriptJan 18, 2022
- Q3 2021 ATAI Life Sciences NV Earnings Call TranscriptNov 15, 2021$12.85 (-13.87%)Earnings
- ATAI Life Sciences NV at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- ATAI Life Sciences NV at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
Q2 2022 ATAI Life Sciences NV Earnings Presentation Transcript
Aug 15, 2022 / 12:30PM GMT
Release Date Price:
$4.68
(+2.18%)
Gregory L. Weaver
Atai Life Sciences N.V. - CFO
Presentation
Aug 15, 2022 / 12:30PM GMT
=====================
Corporate Participants
=====================
* Florian Brand
Atai Life Sciences N.V. - Co-Founder, MD & CEO
* Gregory L. Weaver
Atai Life Sciences N.V. - CFO
* Srinivas G. Rao
Atai Life Sciences N.V. - Co-Founder & Chief Scientific Officer
* Stephen B. Bardin
Atai Life Sciences N.V. - CFO
=====================
Conference Call Participants
=====================
* Judah C. Frommer
Crédit Suisse AG, Research Division - Senior Analyst
* Lin Tsai
Jefferies LLC, Research Division - Equity Analyst
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)